Glycopyrrolate Injection
Product Images NDC 70700-903

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 70700-903). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xiromed, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate-spl-20ml-carton (Glycopyrrolate Spl 20ml Carton)

Packaging label for Glycopyrrolate Injection, USP, 4 mg/20 mL (0.2 mg/mL), a human prescription drug by Xiromed, LLC. The label highlights intramuscular or intravenous use, presence of benzyl alcohol, and states it is not for use in newborns. The box contains 10 multiple dose vials of 20 mL each. The product is branded as NovaPlus.*

FDA Label Image

Glycopyrrolate-spl-20ml-container-label (Glycopyrrolate Spl 20ml Container Label)

Label for Glycopyrrolate Injection, USP 4 mg/20 mL (0.2 mg/mL) in a 20 mL multiple dose vial. The label indicates intramuscular or intravenous administration, contains benzyl alcohol, and notes it is not for use in newborns. Manufactured for Xiromed, LLC, Florham Park, NJ. Includes lot and expiration date fields and storage instructions at 20° to 25°C (68° to 77°F).*

FDA Label Image

Glycopyrrolate-spl-5ml-carton (Glycopyrrolate Spl 5ml Carton)

Glycopyrrolate Injection, USP 0.2 mg/mL (1 mg/5 mL) multiple dose vial carton labeling by Xiromed, LLC. The box is designed for 25 vials, with intramuscular or intravenous administration route, containing benzyl alcohol as preservative, and states not for use in newborns. The label includes storage instructions and a barcode.*

FDA Label Image

Glycopyrrolate-spl-5ml-container-label (Glycopyrrolate Spl 5ml Container Label)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) multiple dose vial by Xiromed, LLC. The label includes warnings such as not for use in newborns and specifies use for intramuscular or intravenous administration. It lists ingredients, storage conditions, barcode, and manufacturing information.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

Chemical structure of glycopyrrolate showing its molecular formula C19H28BrNO3 and molecular weight 398.33.*

FDA Label Image

Novaplus-logo.jpg (Np Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.